Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Accured Expenses (2016 - 2026)

Anaptysbio filings provide 11 years of Change in Accured Expenses readings, the most recent being -$17.8 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 25.86% to -$17.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$81.1 million, a 53.92% decrease, with the full-year FY2025 number at -$87.3 million, down 158.08% from a year prior.
  • Change in Accured Expenses hit -$17.8 million in Q1 2026 for Anaptysbio, up from -$22.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.5 million in Q1 2023 to a low of -$40.0 million in Q4 2024.
  • Median Change in Accured Expenses over the past 5 years was -$1.5 million (2023), compared with a mean of -$7.0 million.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 8706.67% in 2023 and later plummeted 2573.36% in 2024.
  • Anaptysbio's Change in Accured Expenses stood at $4.8 million in 2022, then crashed by 131.0% to -$1.5 million in 2023, then plummeted by 2573.36% to -$40.0 million in 2024, then soared by 44.04% to -$22.4 million in 2025, then increased by 20.49% to -$17.8 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$17.8 million (Q1 2026), -$22.4 million (Q4 2025), and -$18.6 million (Q3 2025) per Business Quant data.